pharma&
Livia B. currently serves as Director of Operational Excellence at pharma& since November 2024. Prior experience includes roles at MAM Baby as Global Lead Executive Projects & Business Intelligence and Chief Of Staff / Executive Project Manager from January 2022 to November 2024, and as a Consultant in the Healthcare Practice at The Boston Consulting Group (BCG) from January 2018 to July 2021, focusing on MedTech and Pharma. Livia has a robust background in Big Data & Analytics, Digitalization, Growth Strategy, and Post Merger Integration among other areas. Educational qualifications include a Master's degree in Biomedical Engineering and a Bachelor's degree in Chemical & Process Engineering from Technische Universität Wien, complemented by a Diploma Supplement on Innovation from the same institution. Additional research experience was gained at Technische Universität Wien and the Ecole polytechnique fédérale de Lausanne in the MedTech field.
This person is not in any teams
pharma&
1 followers
pharmaand GmbH (pharma&), a privately owned global company, aspires to breathe new life into proven medicines through our agile and fully integrated business model, guaranteeing the enduring availability, dependability, and quality of essential drugs worldwide that patients and healthcare providers rely on. Whether a former blockbuster or niche medicine, we acquire the worldwide rights to specialty treatments to secure long-term access to established and essential medicines across various specialized therapy areas, doing whatever it takes to maintain and develop the value of these medicines for all who depend on them. We’ve acquired and integrated 11 medicines over the past five years, expanding our portfolio across a wide range of therapy areas, with an increasing focus on hematology and oncology treatments. Our unique, fully integrated model across pharma&’s subsidiaries, joint ventures, and partners enables us to provide our portfolio of medicines to eligible healthcare providers and patients worldwide, spanning the continuum of manufacturing, distribution, administration/access, and patient support.